News
RHHBY
56.37
-0.88%
-0.50
Roche gains expanded use of diagnostic tests to identify eligible Ziihera patients
Seeking Alpha · 1d ago
Roche receives FDA approval for companion diagnostic tests for Ziihera
TipRanks · 1d ago
Eli Lilly Stock (LLY) in Focus as Alzheimer Blood Test Gets FDA Approval
TipRanks · 1d ago
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade)
Seeking Alpha · 1d ago
Vanguard Dividend ETFs Comparison: VYMI vs. VIG vs. VYM for Income Investors
TipRanks · 2d ago
Genentech in up to $2.3B deal with Hanmi for novel weight loss drug
Seeking Alpha · 2d ago
Regeneron: Why I Still See Upside After The Rally
Seeking Alpha · 2d ago
Eli Lilly Stock (LLY) Gains on FDA Approval for Alzheimer’s Blood Test Developed with Roche
TipRanks · 3d ago
Azenta appoints board member Martin Madaus interim CEO as John Marotta exits
Seeking Alpha · 3d ago
Roche’s Alzheimer’s blood test wins FDA clearance
Seeking Alpha · 3d ago
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
Dow Jones · 3d ago
Quest Diagnostics to offer FDA-cleared Roche pTau217 blood test
TipRanks · 3d ago
Labcorp to offer Elecsys pTau-217 test for Alzheimer’s disease
TipRanks · 3d ago
Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer's disease assessment across primary and specialty care
PR Newswire · 3d ago
Weekly Report: what happened at RHHBY last week (0817-0821)?
Weekly Report · 3d ago
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors
Seeking Alpha · 5d ago
Roche's U.S. Subsidiary Genentech to Invest $750 Million in Manufacturing Expansion
Dow Jones · 08/20 16:06
Roche’s Genentech unit to build $750M fill-finish facility in Ohio
Seeking Alpha · 08/20 15:42
Roche’s Genentech announces $750M manufacturing expansion in Hillsboro, GA
TipRanks · 08/20 15:05
Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance
Seeking Alpha · 08/20 12:00
More
Webull provides a variety of real-time RHHBY stock news. You can receive the latest news about Roche Hldg through multiple platforms. This information may help you make smarter investment decisions.
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.